IP Library Granted Patent US 9,499,795
Granted Patent B2
US 9,499,795 · App. 13/962,978 · Granted Nov 22, 2016

PDX1-expressing dorsal and ventral foregut endoderm

Inventors: Kevin Allen D'Amour (San Diego, CA); Alan D. Agulnick (San Diego, CA); Susan Eliazer (San Diego, CA); Emmanuel E. Baetge (Encinitas, CA)
Assignee: ViaCyte, Inc.
C12N5/0676C07K16/18C12N5/0603C12N2501/119C12N2501/155C12N2501/16C12N2501/385C12N2501/405C12N2501/41C12N2501/415C12N2502/13C12N2506/02C12N2510/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,499,795
App. No.
13/962,978
Granted
Nov 22, 2016
Kind
B2
Abstract

Disclosed herein are cell cultures comprising dorsal and/or ventral PDX1-positive foregut endoderm cells and methods of producing the same. Also disclosed herein are cell populations comprising substantially purified dorsal and/or ventral PDX1-positive foregut endoderm cells as well as methods for enriching, isolating and purifying dorsal and/or ventral PDX1-positive foregut endoderm cells from other cell types. Methods of identifying differentiation factors capable of promoting the differentiation of dorsal and/or ventral PDX1-positive foregut endoderm cells, are also disclosed.

Claims (11)

1. An in vitro cell culture comprising human definitive endoderm cells, human pancreatic-duodenal homeobox factor-1 (PDX1) positive foregut endoderm cells, and a medium comprising an effective amount of a TGFβ superfamily member and an effective amount of a retinoid, wherein the effective amount of a TGFβ superfamily member and retinoid promote differentiation of definitive endoderm cells to PDX1-positive foregut endoderm cells, wherein the TGFβ superfamily member is activin A and wherein the retinoid is retinoic acid.

2. The cell culture of claim 1 , wherein at least a portion of the PDX1 positive foregut endoderm cells express the PDX1 protein.

3. The cell culture of claim 1 , wherein at least 10% of human cells in said in vitro culture are PDX1-positive foregut endoderm cells.

4. The cell culture of claim 1 , wherein at least 60% of human cells in said in vitro culture are PDX1-positive foregut endoderm cells.

5. The cell culture of claim 1 , wherein at least 75% of human cells in said in vitro culture are PDX1-positive foregut endoderm cells.

6. The cell culture of claim 1 , wherein the PDX1-positive foregut endoderm cells are selected from the group consisting of PDX1-positive dorsally-biased endoderm cells and PDX1-positive ventrally-biased endoderm cells.

7. The cell culture of claim 1 , wherein the PDX1-positive foregut endoderm cells are PDX1-positive dorsally-biased foregut endoderm cells.

8. The cell culture of claim 1 , wherein said PDX1-positive endoderm cells are derived in vitro from human pluripotent cells.

9. The cell culture of claim 8 , wherein said human pluripotent cells do not form embryoid bodies prior to differentiation.

10. The cell culture of claim 1 , wherein activin A is provided at a concentration of least 25 ng/ml.

11. The cell culture of claim 10 , wherein the retinoic acid is provided at a concentration of about 2 μM.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2016
From: D'AMOUR, KEVIN; AGULNICK, ALAN D.; ELIAZER, SUSAN; BAETGE, E. EDWARD
To: CYTHERA, INC.
Reel/Frame 039569/0520 →
CHANGE OF NAME Recorded Aug 29, 2016
From: CYTHERA, INC.
To: VIACYTE, INC.
Reel/Frame 039862/0947 →
Continuity (4)
Division 12729084 · Mar 22, 2010
Continuation 11588693 · Oct 27, 2006
Provisional Application 60730917 · Oct 27, 2005
Related Publication 20130316357A1 · Nov 28, 2013